An absence of the SMN1 peak identifies SMA patients, and the SMN2 peak provides an internal control for a successful reaction, as complete absence of SMN1 and SMN2 is lethal and every individual has at least one SMN1 or one SMN2 gene copy. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.